Skip to main content
Top
Published in: Acta Diabetologica 1/2011

01-03-2011 | Original Article

The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects

Authors: Reza Meshkani, Mehryar Zargari, Bagher Larijani

Published in: Acta Diabetologica | Issue 1/2011

Login to get access

Abstract

Elevated serum uric acid (SUA) concentrations have been suggested to associate with metabolic syndrome (MetS) and its components. However, limited information is available regarding the relationship between SUA and MetS in subjects with normal glucose levels. A total of 501 subjects with normal fasting glucose and normal glucose tolerance were included in the study. Anthropometrical and biochemical parameters were examined using standard methods. The updated NECP criteria were used to define the MetS. Values of SUA above the sex-specific percentile 75 were used to define hyperuricemia. The prevalence of general and abdominal obesity, hypertension, hypertriglyceridemia, low-HDL, smokers, MetS and insulin resistance was significantly greater in the fourth SUA quartile. Multiple regression indicated that SUA was independently predicted by BMI, triglyceride and 2 h glucose in women, and BMI, triglyceride, 2 h glucose and cholesterol in men. Logistic regression analysis showed that the obesity, hypertriglyceridemia, MetS and insulin resistance were independent determinants of hyperuricemia in women. In men, hyperuricemia was associated with the obesity, hypertriglyceridemia and hypercholesterolemia. Factor analysis yielded three factors interpreted as weight/waist, blood pressure and lipid/glucose. Including SUA in the model did not affect total variance of factor analysis. Our results indicate that SUA is associated with MetS and its components even in subjects with normal glucose levels. General obesity was the major determinant of hyperuricemia in this population. The data from this study do not show the contribution of SUA as an additional component of the MetS.
Literature
1.
go back to reference Reaven GM (2005) The insulin resistance syndrome: definition, dietary approaches to treatment. Ann Rev Nut 25:391–406CrossRef Reaven GM (2005) The insulin resistance syndrome: definition, dietary approaches to treatment. Ann Rev Nut 25:391–406CrossRef
2.
go back to reference Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP (2004) National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251–1257PubMedCrossRef Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP (2004) National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251–1257PubMedCrossRef
3.
go back to reference Dekker JM, Girman C, Rhodes T et al (2005) Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112:666–673PubMedCrossRef Dekker JM, Girman C, Rhodes T et al (2005) Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112:666–673PubMedCrossRef
4.
go back to reference Butler J, Rodondi N, Zhu Y et al (2006) Metabolic syndrome and the risk of cardiovascula disease in older adults. J Am Coll Cardiol 47:1595–1602PubMedCrossRef Butler J, Rodondi N, Zhu Y et al (2006) Metabolic syndrome and the risk of cardiovascula disease in older adults. J Am Coll Cardiol 47:1595–1602PubMedCrossRef
5.
go back to reference Meigs JB, Mittleman MA, Nathan DM et al (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study. JAMA 283:221–228PubMedCrossRef Meigs JB, Mittleman MA, Nathan DM et al (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study. JAMA 283:221–228PubMedCrossRef
6.
go back to reference Ramakrishna V, Jailkhani R (2008) Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 45:41–46PubMedCrossRef Ramakrishna V, Jailkhani R (2008) Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 45:41–46PubMedCrossRef
7.
go back to reference Fu CC, Wu DA, Wang JH, Yang WC, Tseng CH (2009) Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetol 46:127–134PubMedCrossRef Fu CC, Wu DA, Wang JH, Yang WC, Tseng CH (2009) Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetol 46:127–134PubMedCrossRef
8.
go back to reference Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, Wang Y (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol (in press) Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, Wang Y (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol (in press)
9.
go back to reference Ko GT, Cockram CS, Chow CC et al (2005) High prevalence of metabolic syndrome in Hong Kong Chinese—comparison of three diagnostic criteria. Diabetes Res Clin Pract 69:160–168PubMedCrossRef Ko GT, Cockram CS, Chow CC et al (2005) High prevalence of metabolic syndrome in Hong Kong Chinese—comparison of three diagnostic criteria. Diabetes Res Clin Pract 69:160–168PubMedCrossRef
10.
go back to reference Simmons D, Thompson CF (2004) Prevalence of the metabolic syndrome among adult New Zealanders of Polynesian and European descent. Diabetes Care 27:3002–3004PubMedCrossRef Simmons D, Thompson CF (2004) Prevalence of the metabolic syndrome among adult New Zealanders of Polynesian and European descent. Diabetes Care 27:3002–3004PubMedCrossRef
11.
go back to reference Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003) Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61:29–37PubMedCrossRef Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003) Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61:29–37PubMedCrossRef
12.
go back to reference Facchini F, Chen YD, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008–3011PubMedCrossRef Facchini F, Chen YD, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008–3011PubMedCrossRef
13.
go back to reference Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E (1996) Serum uric acid and related factors in 500 hospitalized subjects. Metabolism 45:1557–1561PubMedCrossRef Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E (1996) Serum uric acid and related factors in 500 hospitalized subjects. Metabolism 45:1557–1561PubMedCrossRef
14.
go back to reference Bonora E, Targher G, Zenere MB et al (1996) Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20:975–980PubMed Bonora E, Targher G, Zenere MB et al (1996) Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20:975–980PubMed
15.
go back to reference Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP (2005) The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 21:1157–1159PubMedCrossRef Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP (2005) The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 21:1157–1159PubMedCrossRef
16.
go back to reference Zimmet PZ, Collins VR, Dowse GK et al (1994) Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabet Med 11:388–396PubMedCrossRef Zimmet PZ, Collins VR, Dowse GK et al (1994) Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabet Med 11:388–396PubMedCrossRef
17.
go back to reference Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS (2006) Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 55:1293–1301PubMedCrossRef Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS (2006) Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 55:1293–1301PubMedCrossRef
18.
go back to reference Yoo TW, Sung KC, Shin HS et al (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69:928–933PubMedCrossRef Yoo TW, Sung KC, Shin HS et al (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69:928–933PubMedCrossRef
19.
go back to reference Lin SD, Tsai DH, Hsu SR (2006) Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 69:512–516PubMedCrossRef Lin SD, Tsai DH, Hsu SR (2006) Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 69:512–516PubMedCrossRef
20.
go back to reference Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG (2000) Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 23:1242–1248PubMedCrossRef Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG (2000) Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 23:1242–1248PubMedCrossRef
21.
go back to reference Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215PubMedCrossRef Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215PubMedCrossRef
22.
go back to reference Expert Committee on the diagnosis, classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 Expert Committee on the diagnosis, classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
23.
go back to reference Meshkani R, Taghikhnai M, larijani B, Khatami Sh, Khoshbin E, Adeli K (2006) The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 371:169–175PubMedCrossRef Meshkani R, Taghikhnai M, larijani B, Khatami Sh, Khoshbin E, Adeli K (2006) The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 371:169–175PubMedCrossRef
24.
go back to reference Onat A, Avc GS, Senocak M, Ornek E, Gozukara Y (1992) Plasma lipid and their interaction in Turkish adults. J Epidemiol Community Health 45:470–476CrossRef Onat A, Avc GS, Senocak M, Ornek E, Gozukara Y (1992) Plasma lipid and their interaction in Turkish adults. J Epidemiol Community Health 45:470–476CrossRef
25.
go back to reference Expert Committee on the diagnosis, classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 Expert Committee on the diagnosis, classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
26.
go back to reference Genuth S, Alberti KG, Bennett P et al (2003) Expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26:3160–3167PubMedCrossRef Genuth S, Alberti KG, Bennett P et al (2003) Expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26:3160–3167PubMedCrossRef
27.
go back to reference Goke B (1998) Implications of blood glucose, insulin resistance and beta-cell function in impaired glucose tolerance. Diabetes Res Clin Pract 40:S15–S20PubMedCrossRef Goke B (1998) Implications of blood glucose, insulin resistance and beta-cell function in impaired glucose tolerance. Diabetes Res Clin Pract 40:S15–S20PubMedCrossRef
28.
go back to reference Heinig M, Johnson RJ (2006) Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73:1059–1064PubMedCrossRef Heinig M, Johnson RJ (2006) Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73:1059–1064PubMedCrossRef
29.
go back to reference Nakagawa T, Hu H, Zharikov S et al (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290:F625–F631PubMedCrossRef Nakagawa T, Hu H, Zharikov S et al (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290:F625–F631PubMedCrossRef
30.
go back to reference Baldus S, Koster R, Chumley P, Heitzer T et al (2005) Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 39:1184–1190PubMedCrossRef Baldus S, Koster R, Chumley P, Heitzer T et al (2005) Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 39:1184–1190PubMedCrossRef
31.
go back to reference Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 27:227–233PubMedCrossRef Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 27:227–233PubMedCrossRef
32.
go back to reference Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K (2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18:523–530PubMedCrossRef Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K (2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18:523–530PubMedCrossRef
33.
go back to reference Krishnan E, Kwoh CK, Schumacher HR, Kuller L (2007) Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 49:298–303PubMedCrossRef Krishnan E, Kwoh CK, Schumacher HR, Kuller L (2007) Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 49:298–303PubMedCrossRef
34.
go back to reference Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ (2007) Associations of serum uric Acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20:83–89PubMedCrossRef Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ (2007) Associations of serum uric Acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20:83–89PubMedCrossRef
35.
go back to reference Bonora E, Kiechl S, Willeit J et al (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643–1649PubMedCrossRef Bonora E, Kiechl S, Willeit J et al (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643–1649PubMedCrossRef
36.
go back to reference Onat A, Uyarel H, Hergenc G et al (2006) Serum uric acid I is a determinant of metabolic syndrome in a population-based study. Am J Hypert 19:1055–1062CrossRef Onat A, Uyarel H, Hergenc G et al (2006) Serum uric acid I is a determinant of metabolic syndrome in a population-based study. Am J Hypert 19:1055–1062CrossRef
37.
go back to reference Nan H, Qiao Q, Soderberg S et al (2008) Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. Metab Syndr Relat Disord 6:47–57PubMedCrossRef Nan H, Qiao Q, Soderberg S et al (2008) Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. Metab Syndr Relat Disord 6:47–57PubMedCrossRef
38.
go back to reference Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentration in human. Jpn Heart J 44:527–536PubMedCrossRef Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentration in human. Jpn Heart J 44:527–536PubMedCrossRef
39.
go back to reference Nakanishi N, Suzuki K, Kawashimo H, Nakamura K, Tatara K (1999) Serum uric acid: correlation with biological, clinical and behavioral factors in Japanese men. J Epidemiol 9:99–106PubMed Nakanishi N, Suzuki K, Kawashimo H, Nakamura K, Tatara K (1999) Serum uric acid: correlation with biological, clinical and behavioral factors in Japanese men. J Epidemiol 9:99–106PubMed
40.
go back to reference Fox IH, John D, DeBruyne S, Dwosh I, Marliss EB (1985) Hyperuricemia and hypertriglyceridemia: metabolic basis for the association. Metabolism 34:741–746PubMedCrossRef Fox IH, John D, DeBruyne S, Dwosh I, Marliss EB (1985) Hyperuricemia and hypertriglyceridemia: metabolic basis for the association. Metabolism 34:741–746PubMedCrossRef
41.
go back to reference Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006PubMedCrossRef Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006PubMedCrossRef
42.
go back to reference Whitehead TP, Jungner I, Robinson D, Kolar W, Pearl A, Hale A (1992) Serum urate, serum glucose and diabetes. Ann Clin Biochem 29:159–161PubMed Whitehead TP, Jungner I, Robinson D, Kolar W, Pearl A, Hale A (1992) Serum urate, serum glucose and diabetes. Ann Clin Biochem 29:159–161PubMed
43.
go back to reference Tinahones FJ, Cardona F, Rojo-Martínez G et al (2008) Decreased levels of uric acid after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance. Brit J Nut 99:44–48CrossRef Tinahones FJ, Cardona F, Rojo-Martínez G et al (2008) Decreased levels of uric acid after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance. Brit J Nut 99:44–48CrossRef
44.
go back to reference Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels—the Third National Health and Nutrition Examination Survey. Rheumatology 47:713–717PubMedCrossRef Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels—the Third National Health and Nutrition Examination Survey. Rheumatology 47:713–717PubMedCrossRef
45.
go back to reference Nakagawa T, Tuttle KR, Short RA, Johnson RJ (2005) Fructose induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Nephrol 1:80–86CrossRef Nakagawa T, Tuttle KR, Short RA, Johnson RJ (2005) Fructose induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Nephrol 1:80–86CrossRef
46.
go back to reference Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST (2008) Uric acid: a surrogate of insulin resistance in older women. Maturitas 59:55–61PubMedCrossRef Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST (2008) Uric acid: a surrogate of insulin resistance in older women. Maturitas 59:55–61PubMedCrossRef
47.
go back to reference Liou TL, Lin MW, Hsiao LC et al (2006) Is hyperuricemia another facet of the metabolic syndrome? J Chin Med Assoc 69:104–109PubMedCrossRef Liou TL, Lin MW, Hsiao LC et al (2006) Is hyperuricemia another facet of the metabolic syndrome? J Chin Med Assoc 69:104–109PubMedCrossRef
48.
go back to reference Sheu WH, Tseng YH (2006) Uric acid: an additional component of metabolic syndrome? J Chin Med Assoc 69:99–100PubMedCrossRef Sheu WH, Tseng YH (2006) Uric acid: an additional component of metabolic syndrome? J Chin Med Assoc 69:99–100PubMedCrossRef
49.
go back to reference Ryu S, Song J, Choi BY et al (2007) Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol 17:245–252PubMedCrossRef Ryu S, Song J, Choi BY et al (2007) Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol 17:245–252PubMedCrossRef
50.
go back to reference Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN (2008) Uric acid and the development of metabolic syndrome in women and men. Metabolism 57:845–852PubMedCrossRef Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN (2008) Uric acid and the development of metabolic syndrome in women and men. Metabolism 57:845–852PubMedCrossRef
Metadata
Title
The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects
Authors
Reza Meshkani
Mehryar Zargari
Bagher Larijani
Publication date
01-03-2011
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2011
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0231-3

Other articles of this Issue 1/2011

Acta Diabetologica 1/2011 Go to the issue

Review Article

The IGF system

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.